Is a complete SHE/300942 research report available?

No complete published report is available for she/300942 (SHE/300942) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/300942 stock profile: metrics, valuation and analysis

Market cap	2.7B
Revenue (ttm)	282.3M
Net income (ttm)	-8.3M
EPS (ttm)	-CN¥0.02
Shares out	405.1M
Dividend	CN¥0.02 (0.37%)
Volume	580,283
Beta	0.53

All SHE/300942 indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

CNY

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	542
Employees Change	62%
Employees Change Percent	12.92
Enterprise value	CNY 2.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	41.42
Isin	CNE100004C78
Last refreshed	2026-09-08
Market cap	CNY 2.7B
Price	CNY 6.52
Price currency	CNY
Rev Per Employee	520,862.35x
Sector	Healthcare
Sector PE	40.46
Sector PE Fwd	21.02
Sic	2835
Symbol	she/300942
Website	https://www.bioeasy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.31%
EV/EBIT	191.59x
EV/EBITDA	51.64x
EV/Sales	8.99x
FCF yield	-0%
P/B ratio	3.01x
P/S ratio	9.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.69%
EBITDA Margin	17.42%
Gross margin	60.75%
Gross Profit	CNY 171.5M
Gross Profit Growth	10.49%
Gross Profit Growth Q	-1.96%
Gross Profit Growth3 Y	36.29%
Gross Profit Growth5 Y	-12.95%
Net Income	CNY -8.3M
Net Income Growth Years	0%
Pretax Margin	-4.08%
Profit Margin	-2.95%
Profit Per Employee	CNY -15,356
Profitable Years	2
ROA	0.57
Roa5y	3.37
ROCE	0.97
ROE	-0.67
Roe5y	4.71
ROIC	1.74
Roic5y	18.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-49.61%
Cagr3y	-22.48%
Cagr5y	-26.67%
Div CAGR3	5.2%
EPS Growth Years	0
OCF Growth	215.78%
OCF Growth Q	377.15%
OCF Growth3 Y	-1.74%
OCF Growth5 Y	-24.83%
Revenue Growth	22.8x
Revenue Growth Q	17.98x
Revenue Growth Qo Q	22.69x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.52x
Revenue Growth5 Y	-9.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 1.5B
Cash	CNY 584.2M
Current Assets	CNY 794.1M
Current Liabilities	CNY 120.1M
Debt	CNY 463.6M
Debt EBITDA	CNY 9.43
Debt Equity	CNY 0.53
Debt FCF	CNY -12,300
Equity	CNY 880.4M
Interest Coverage	0.97
Liabilities	CNY 599.7M
Long Term Assets	CNY 686.1M
Long Term Liabilities	CNY 479.6M
Net Cash	CNY 120.5M
Net Cash By Market Cap	CNY 4.54
Net Cash Growth	37.03%
Net Debt EBITDA	CNY -2.45
Net Debt Equity	CNY -0.14
Tangible Book Value	CNY 837.6M
Tangible Book Value Per Share	CNY 2.07
WACC	6.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.61
Inventory Turnover	1.89
Net Working Capital	CNY 115.2M
Quick ratio	5.87
Working Capital	CNY 674M
Working Capital Turnover	CNY 0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.82%
Dividend Growth	41.51%
Dividend Growth Years	0%
Dividend per share	CNY 0.02
Dividend Years	2
Dividend Yield	0.37%
Ex Div Date	2026-06-03
Last Dividend	CNY 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-49.58%
200-day SMA	8.2
3Y total return	-53.42%
50-day SMA	6.41
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.79%
All Time High	52.8
All Time High Change	-87.59%
All Time High Date	2021-02-09
All Time Low	5.25
All Time Low Change	24.76%
All Time Low Date	2024-02-08
ATR	0.27
Beta	0.53
Beta1y	0.56
Beta2y	0.75
Ch YTD	-30.39
High	6.57
High52	13
High52 Date	2025-09-08
High52ch	-49.85%
Low	6.48
Low52	5.55
Low52 Date	2026-06-29
Low52ch	17.48%
Ma50ch	2.18%
Price vs 200-day SMA	-20.12%
RSI	47.71
RSI Monthly	37.92
RSI Weekly	40.08
Sharpe ratio	-1.56x
Sharpe Ratio3y	-0.19x
Sharpe Ratio5y	-0.32x
Sortino ratio	-1.98
Sortino Ratio3y	-0.17
Sortino Ratio5y	-0.37
Total Return	-6.45%
Tr YTD	-30.14
Tr1m	-2.09%
Tr1w	-1.5%
Tr3m	1.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	150,347,690%
Net Borrowing	21,436,772
Shares Insiders	22.58%
Shares Institutions	3.09%
Shares Out	405,077,895
Shares Qo Q	-0.22%
Shares Yo Y	6.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	9,967,298.5x
Bv Per Share	2.16
CAPEX	CNY -61.1M
Ch1m	-2.09
Ch1w	-1.5
Ch1y	-49.77
Ch3m	1.39
Ch3y	-53.68
Ch5y	-79.18
Ch6m	-30.39
Change	-0.46%
Change From Open	-0.46
Close	6.55
Days Gap	0
Depreciation Amortization	35,918,933
Dollar Volume	3,783,445.2
Earnings Date	2026-08-28
EBIT	CNY 13.3M
EBITDA	CNY 49.2M
EPS	CNY -0.02
F Score	5
FCF	CNY -37,696
FCF EV Yield	-0x
FCF Per Share	CNY -0
Financing CF	7,880,866
Fiscal Year End	December
Founded	2,007
Income Tax	CNY -5.7M
Investing CF	-48,577,430
Is Primary Listing	1
Last Earnings Date	2026-08-28
Last Report Date	2026-06-30
Ma150	7.61
Ma150ch	-13.95%
Ma20	6.74
Ma20ch	-2.88%
Net CF	5,613,954
Next Earnings Date	2026-10-27
Open	6.55
P OCF Ratio	43.48
Payment Date	2026-06-03
Position In Range	44.44
Ppne	568,435,081
Price Date	2026-09-08
Price EBITDA	CNY 53.96
Ptbv Ratio	3.17
Relative Volume	0.06x
Revenue	282,307,391x
Tax By Revenue	-2.02x
Tr6m	-30.14%
Volume	580,283

SHE/300942 (SHE/300942)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300942

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300942 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/300942

Frequently asked questions